Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
197
datasets available to search
ShareScore release 0.7.1
Dataset results
197 results for “BCMA”
Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM
ClinicalTrials.gov study NCT05594797. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Ma
ClinicalTrials.gov study NCT05836896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
ClinicalTrials.gov study NCT07305116. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05376345. IPD Sharing: NO. Countries: 1. Publications: 0.
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT07155369. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)
ClinicalTrials.gov study NCT05181501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07258511. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05535244. IPD Sharing: YES. Countries: 8. Publications: 0.
BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03661554. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04318327. IPD Sharing: NO. Countries: 4. Publications: 0.
A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
ClinicalTrials.gov study NCT07376720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
ClinicalTrials.gov study NCT04287660. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT05243212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04394650. IPD Sharing: YES. Countries: 1. Publications: 0.
To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
ClinicalTrials.gov study NCT06045091. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03716856. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04036461. IPD Sharing: YES. Countries: 5. Publications: 0.
Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06242249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BCMA CAR-T in Multiple Myeloma
ClinicalTrials.gov study NCT03322735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
ClinicalTrials.gov study NCT06947473. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.